TRENDING : Top 50   TVIX (0%)    VXX (0%)    EEM (0%)    GM (0%)    MA (0%)    SPY (0%)    XLY (0%)    AMZN (0%)    BTCUSD (%)    CLBS (0%)    ABMD (0%)    AAPL (0%)    FB (0%)    GEVO (0%)    GS (0%)    IPGP (0%)    JD (0%)    NFLX (0%)    PEP (0%)    SEDG (0%)    SPX (0%)    EWI (0%)    CBIO (0%)    CARA (0%)    CANF (0%)

GLMD - Galmed Pharmaceuticals Ltd.

$14.39 (0%)



RECENT SUCCESSFUL RECOMMENDATIONS

SymbolService NamePosition TypeIssuePrice Price Target Close Date% Return Comments
GLMDBiotech picksSell Short$16.60$10.006/13/20189.94 %CommentsView Details

RECENT RECOMMENDATIONS

Stocks

No recommendations found.

Options

No recommendations found.


** Recommendations from last 7 days only. Subscribe to different services to see past recommendations

TRENDING ARTICLES


3 Biotech Stocks That Soared This Week: Are They Buys?

NASDAQ NEWS   -  6/16/2018

An Ear To The Pharma: 5 Stocks To Watch (OBSV, GERN, SRPT…)

NASDAQ NEWS   -  6/16/2018

3 NASH Stocks That Could Soar in the Second Half of 2018

NASDAQ NEWS   -  6/15/2018

Are These Red-Hot NASH Stocks Still a Buy?

NASDAQ NEWS   -  6/14/2018

NASH Space in Focus as Galmed (GLMD) Posts Positive Data

NASDAQ NEWS   -  6/14/2018

Galmed (GLMD) Soars on Positive NASH Data on Aramchol

NASDAQ NEWS   -  6/13/2018

GLMD Arrests Investor Attention, SAGE Excited, GEMP On Close Watch

NASDAQ NEWS   -  6/12/2018

Why Galmed Pharmaceuticals Ltd Stock Is Going Gangbusters Today

NASDAQ NEWS   -  6/12/2018

Close Update: Stocks Trim Losses As Wall Street Pivots From Geopolitics to Central Banks

NASDAQ NEWS   -  6/12/2018

Why Galmed Pharmaceuticals Ltd. Stock Is Skyrocketing Today

NASDAQ NEWS   -  6/12/2018

Patience Pays Off For Galmed Investors...

NASDAQ NEWS   -  6/12/2018

Pre-Market Earnings Report for March 13, 2018 : HDS, DKS, GDS, DSW, EPZM, NRE, ATRS, MLNT, ARLZ, GNMX, TSQ, GLMD

NASDAQ NEWS   -  3/12/2018

3 Reasons Why Galmed Pharmaceuticals (GLMD) is a Great Momentum Stock

NASDAQ NEWS   -  9/5/2017

Galmed Pharmaceuticals (GLMD) Catches Eye: Stock Gains 15.7%

NASDAQ NEWS   -  7/25/2017

Pre-Market Earnings Report for May 15, 2017 : SPNS, SPP, WLB, VBLT, BDSI, SORL, MARK, ALDX, GLMD, NTWK, REED, DGLY

NASDAQ NEWS   -  5/12/2017

Nonalcoholic Steatohepatitis (NASH): What's The Market Opportunity And Who Are The Major Players?

NASDAQ NEWS   -  9/29/2016

5 Biotech Stocks to Watch as Interest in NASH Increases

NASDAQ NEWS   -  9/22/2016

Biotech ETFs in Focus on Tobira Therapeutics' Massive Gain

NASDAQ NEWS   -  9/21/2016